Blueberries Medical Corp.
BBRRF
$0.009
-$0.0023-20.35%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | 341.20K | 195.60K | 213.10K | 222.10K | 213.80K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 341.20K | 195.60K | 213.10K | 222.10K | 213.80K |
Cost of Revenue | 222.00K | 97.60K | 138.00K | 135.60K | 151.40K |
Gross Profit | 119.30K | 98.10K | 75.30K | 86.50K | 62.40K |
SG&A Expenses | 710.10K | 841.80K | 858.40K | 943.30K | 970.80K |
Depreciation & Amortization | 76.80K | 83.10K | 137.90K | 120.80K | 111.20K |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.01M | 1.02M | 1.13M | 1.20M | 1.23M |
Operating Income | -667.60K | -826.80K | -921.10K | -977.60K | -1.02M |
Income Before Tax | -836.20K | -838.30K | -950.40K | -1.08M | -1.21M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -0.84 | -0.84 | -0.95 | -1.08 | -1.21 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -836.20K | -838.30K | -950.40K | -1.08M | -1.21M |
EBIT | -667.60K | -826.80K | -921.10K | -977.60K | -1.02M |
EBITDA | -590.80K | -745.10K | -784.50K | -858.20K | -909.80K |
EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Basic Shares Outstanding | 1.60B | 1.42B | 1.24B | 1.06B | 877.20M |
Average Diluted Shares Outstanding | 1.60B | 1.42B | 1.24B | 1.06B | 877.20M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |